Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1977 Aug;60(2):390–404. doi: 10.1172/JCI108788

Stabilization of Factor VIII in Plasma by the von Willebrand Factor

STUDIES ON POSTTRANSFUSION AND DISSOCIATED FACTOR VIII AND IN PATIENTS WITH VON WILLEBRAND'S DISEASE

Harvey J Weiss 1,2,3,4, Ira I Sussman 1,2,3,4, Leon W Hoyer 1,2,3,4
PMCID: PMC372380  PMID: 17621

Abstract

In normal plasma, the ratio of the procoagulant activity of factor VIII (VIIIAHF) to that of the von Willebrand factor activity (ristocetin cofactor, VIIIVWF) or factor VIII antigen (VIIIAGN) is ∼1, but ratios > 1 (e.g., VIIIAHF > VIIIVWF or VIIIAGN) may be observed in some patients with von Willebrand's disease and in the “late” posttransfusion plasmas of patients with this disorder. The lability of VIIIAHF was studied by incubating plasma, diluted 1:10 in imidazole buffer pH 7.1, for 6 h at 37°C. With normal plasmas, 77±12% (SD) of the original VIIIAHF activity remained after incubation. VIIIAHF was labile (e.g., 35-55% residual activity) in the “late” posttransfusion plasmas (VIIIAHF ≫ VIIIVWF) of a patient with von Willebrand's disease, but not in the “early” posttransfusion plasmas (VIIIAHF ∼ VIIIVWF). VIIIAHF was also labile in the (base-line) plasmas of three patients with von Willebrand's disease in whom the ratios of VIIIAHF to VIIIVWF were 4.4 to 8.1, but not in the plasmas of four other patients in whom the ratio was ∼ 1. The electrophoretic mobility of factor VIII antigen was increased in two of the three patients with labile VIIIAHF. In both of these patients, and in the late posttransfusion plasmas, labile VIIIAHF activity could be stabilized by the addition of purified von Willebrand factor (lacking VIIIAHF activity) or by hemophilic plasma, but not by plasmas of patients with severe von Willebrand's disease. Thus, VIIIVWF may serve to stabilize VIIIAHF and this might explain the posttransfusion findings in von Willebrand's disease.

Full text

PDF
395

Images in this article

392Image
on p.392
396Image
on p.396
399Image
on p.399

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Austen D. E. Factor VIII of small molecular weight and its aggregation. Br J Haematol. 1974 May;27(1):89–100. doi: 10.1111/j.1365-2141.1974.tb06777.x. [DOI] [PubMed] [Google Scholar]
  2. BARROW E. M., ROBERTS H. R., PONS K., GRAHAM J. B. STUDIES OF THE ANTIHEMOPHILIC FACTOR (AHF, FACTOR VIII) PRODUCED IN VON WILLEBRAND'S DISEASE. Proc Soc Exp Biol Med. 1964 Mar;115:760–763. doi: 10.3181/00379727-115-29030. [DOI] [PubMed] [Google Scholar]
  3. Bennett B., Ratnoff O. D., Levin J. Immunologic studies in von Willebrand's disease. Evidence that the antihemophilic factor (AHF) produced after transfusions lacks an antigen associated with normal AHF and the inactive material produced by patients with classic hemophilia. J Clin Invest. 1972 Oct;51(10):2597–2601. doi: 10.1172/JCI107077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cooper H. A., Griggs T. R., Wagner R. H. Factor VIII recombination after dissociation by CaCl12. Proc Natl Acad Sci U S A. 1973 Aug;70(8):2326–2329. doi: 10.1073/pnas.70.8.2326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cooper H. A., Wagner R. H. The defect in hemophilic and von Willebrand's disease plasmas studied by a recombination technique. J Clin Invest. 1974 Nov;54(5):1093–1099. doi: 10.1172/JCI107853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fass D. N., Bowie E. J., Owen C. A., Jr, Mann K. G. Stability of porcine factor VIII. Thromb Res. 1975 Feb;6(2):109–118. doi: 10.1016/0049-3848(75)90016-x. [DOI] [PubMed] [Google Scholar]
  7. Firkin B., Firkin F., Stott L. Von Willebrand's disease type B: a newly defined bleeding diathesis. Aust N Z J Med. 1973 Jun;3(3):225–229. doi: 10.1111/j.1445-5994.1973.tb03086.x. [DOI] [PubMed] [Google Scholar]
  8. Gralnick H. R., Coller B. S. Molecular defects in haemophilia A and von Willebrand's disease. Lancet. 1976 Apr 17;1(7964):837–838. doi: 10.1016/s0140-6736(76)90485-2. [DOI] [PubMed] [Google Scholar]
  9. Gralnick H. R., Coller B. S., Sultan Y. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease. J Clin Invest. 1975 Oct;56(4):814–827. doi: 10.1172/JCI108160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Holmberg L., Nilsson I. M., Rasovic N. Letter: Factor VIII in von Willebrand's disease. Lancet. 1974 Oct 26;2(7887):1027–1027. doi: 10.1016/s0140-6736(74)92140-0. [DOI] [PubMed] [Google Scholar]
  11. Hougie C., Sargeant R. B., Brown J. E., Baugh R. F. Evidence that factor VIII and the ristocetin aggregating factor (VIIIRist) are separate molecular entities. Proc Soc Exp Biol Med. 1974 Oct;147(1):58–61. doi: 10.3181/00379727-147-38280. [DOI] [PubMed] [Google Scholar]
  12. Hoyer L. W. Immunologic studies of antihemophilic factor (AHF, factor VIII). IV. Radioimmunoassay of AHF antigen. J Lab Clin Med. 1972 Dec;80(6):822–833. [PubMed] [Google Scholar]
  13. Jaffe E. A., Nachman R. L. Subunit structure of factor VIII antigen synthesized by cultured human endothelial cells. J Clin Invest. 1975 Sep;56(3):698–702. doi: 10.1172/JCI108140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. KEKWICK R. A., WALTON P. L. Conditions influencing the stability of human antihaemophilic factor. Nature. 1962 Jun 2;194:878–879. doi: 10.1038/194878a0. [DOI] [PubMed] [Google Scholar]
  15. Kernoff P. B., Gruson R., Rizza C. R. A variant of factor 8 related antigen. Br J Haematol. 1974 Mar;26(3):435–440. doi: 10.1111/j.1365-2141.1974.tb00484.x. [DOI] [PubMed] [Google Scholar]
  16. Legaz M. E., Schmer G., Counts R. B., Davie E. W. Isolation and characterization of human Factor VIII (antihemophilic factor). J Biol Chem. 1973 Jun 10;248(11):3946–3955. [PubMed] [Google Scholar]
  17. Marchesi S. L., Shulman N. R., Gralnick H. R. Studies on the purification and characterization of human factor 8. J Clin Invest. 1972 Aug;51(8):2151–2161. doi: 10.1172/JCI107022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. McKee P. A., Andersen J. C., Switzer M. E. Molecular structural studies of human factor VIII. Ann N Y Acad Sci. 1975 Jan 20;240:8–33. doi: 10.1111/j.1749-6632.1975.tb53319.x. [DOI] [PubMed] [Google Scholar]
  19. Meyer D., Jenkins C. S., Dreyfus M. D., Fressinaud E., Larrieu M. J. Willebrand factor and ristocetin. II. Relationship between Willebrand factor, Willebrand antigen and factor VIII activity. Br J Haematol. 1974 Dec;28(4):579–599. doi: 10.1111/j.1365-2141.1974.tb06676.x. [DOI] [PubMed] [Google Scholar]
  20. Muntz R. H., Ekert H., Helliger H. Properties of post-infusion factor VIII in von Willebrand's disease. Thromb Res. 1974 Aug;5(2):111–123. doi: 10.1016/0049-3848(74)90062-0. [DOI] [PubMed] [Google Scholar]
  21. Newman J., Harris R. B., Johnson A. J. Molecular weights of antihaemophilic factor and von Willebrand factor proteins in human plasma. Nature. 1976 Oct 14;263(5578):612–613. doi: 10.1038/263612a0. [DOI] [PubMed] [Google Scholar]
  22. Owen W. G., Wagner R. H. Antihemophilic factor: separation of an active fragment following dissociation by salts or detergents. Thromb Diath Haemorrh. 1972 Jul 31;27(3):502–515. [PubMed] [Google Scholar]
  23. Peake I. R., Bloom A. L., Giddings J. C. Inherited variants of factor-VIII-related protein in von Willebrand's disease. N Engl J Med. 1974 Jul 18;291(3):113–117. doi: 10.1056/NEJM197407182910301. [DOI] [PubMed] [Google Scholar]
  24. Ratnoff O. D., Slover C. C., Poon M. C. Immunologic evidence that the properties of human antihemophilic factor (factor VIII) are attributes of a single molecular species. Blood. 1976 Apr;47(4):657–667. [PubMed] [Google Scholar]
  25. Rick M. E., Hoyer L. W. Immunologic studies of antihemophilic factor (AHF, factor VIII). V. Immunologic properties of AHF subunits produced by salt dissociation. Blood. 1973 Nov;42(5):737–747. [PubMed] [Google Scholar]
  26. Rick M. E., Hoyer L. W. Molecular weight of human factor VIII procoagulant activity. Thromb Res. 1975 Dec;7(6):909–916. doi: 10.1016/0049-3848(75)90094-8. [DOI] [PubMed] [Google Scholar]
  27. Rickles F. R., Hoyer L. W., Rick M. E., Ahr D. J. The effects of epinephrine infusion in patients with von Willebrand's disease. J Clin Invest. 1976 Jun;57(6):1618–1625. doi: 10.1172/JCI108432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Shapiro G. A., Andersen J. C., Pizzo S. V., McKee P. A. The subunit structure of normal and hemophilic factor VIII. J Clin Invest. 1973 Sep;52(9):2198–2210. doi: 10.1172/JCI107405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Stibbe J., Hemker H. C., von Creveld S. The inactivation of factor VIII in vitro. Thromb Diath Haemorrh. 1972 Feb 29;27(1):43–58. [PubMed] [Google Scholar]
  30. Sultan Y., Simeon J., Caen J. P. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease. J Lab Clin Med. 1976 Feb;87(2):185–194. [PubMed] [Google Scholar]
  31. Sussman I. I., Rosner W., Weiss H. J. Concentration-dependent dissociation of factor VIII in 1 M NaCl. Am J Physiol. 1976 Feb;230(2):434–440. doi: 10.1152/ajplegacy.1976.230.2.434. [DOI] [PubMed] [Google Scholar]
  32. Sussman I. I., Weiss H. J. Spontaneous aggregation of low molecular weight factor viii and its prevention by 2mm cacl2. Thromb Res. 1976 Sep;9(3):267–276. doi: 10.1016/0049-3848(76)90216-4. [DOI] [PubMed] [Google Scholar]
  33. Switzer M. E., McKee P. A. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure. J Clin Invest. 1976 Apr;57(4):925–937. doi: 10.1172/JCI108369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Veltkamp J. J., van Tilburg N. H. Detection of heterozygotes for recessive von Willebrand's disease by the assay of antihemophilic-factor-like antigen. N Engl J Med. 1973 Oct 25;289(17):882–885. doi: 10.1056/NEJM197310252891703. [DOI] [PubMed] [Google Scholar]
  35. WOLF P. Studies of temperature and pH stability of human antihaemophilic factor (AHF) in plasma and in a concentrate. Br J Haematol. 1959 Apr;5(2):169–176. doi: 10.1111/j.1365-2141.1959.tb04022.x. [DOI] [PubMed] [Google Scholar]
  36. Weber K., Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem. 1969 Aug 25;244(16):4406–4412. [PubMed] [Google Scholar]
  37. Weiss H. J. A study of the cation- and pH-dependent stability of factors V and VIII in plasma. Thromb Diath Haemorrh. 1965 Sep 1;14(1-2):32–51. [PubMed] [Google Scholar]
  38. Weiss H. J., Hoyer I. W. Von Willebrand factor: dissociation from antihemophilic factor procoagulant activity. Science. 1973 Dec 14;182(4117):1149–1151. doi: 10.1126/science.182.4117.1149. [DOI] [PubMed] [Google Scholar]
  39. Weiss H. J., Hoyer L. W., Rickles F. R., Varma A., Rogers J. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. J Clin Invest. 1973 Nov;52(11):2708–2716. doi: 10.1172/JCI107465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Weiss H. J., Kochwa S. Molecular forms of antihaemophilic globulin in plasma, cryoprecipitate and after thrombin activation. Br J Haematol. 1970 Jan;18(1):89–100. doi: 10.1111/j.1365-2141.1970.tb01421.x. [DOI] [PubMed] [Google Scholar]
  41. Weiss H. J., Phillips L. L., Rosner W. Separation of sub-units of antihemophilic factor (AHF) by agarose gel chromatography. Thromb Diath Haemorrh. 1972 Apr 30;27(2):212–219. [PubMed] [Google Scholar]
  42. Weiss H. J. Platelet physiology and abnormalities of platelet function (first of two parts). N Engl J Med. 1975 Sep 11;293(11):531–541. doi: 10.1056/NEJM197509112931105. [DOI] [PubMed] [Google Scholar]
  43. Zimmerman T. S., Edgington T. S. Factor VIII coagulant activity and factor VIII-like antigen: independent molecular entities. J Exp Med. 1973 Oct 1;138(4):1015–1020. doi: 10.1084/jem.138.4.1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Zimmerman T. S., Hoyer L. W., Dickson L., Edgington T. S. Determination of the von Willebrand's disease antigen (factor VIII-related antigen) in plasma by quantitative immunoelectrophoresis. J Lab Clin Med. 1975 Jul;86(1):152–159. [PubMed] [Google Scholar]
  45. Zimmerman T. S., Roberts J., Edgington T. S. Factor-VIII-related antigen: multiple molecular forms in human plasma. Proc Natl Acad Sci U S A. 1975 Dec;72(12):5121–5125. doi: 10.1073/pnas.72.12.5121. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES